Gene Therapy Pioneer Jim Wilson Comments on Solid Biosciences’s Announcement of FDA IND Clearance for Friedreich’s Ataxia Treatment
PHILADELPHIA, Jan. 8, 2025 /PRNewswire/ -- Today, Dr. Jim Wilson, President and CEO of GEMMA Biotherapeutics ("GEMMABio") commented on Solid Bioscience's announcement of clearance by the Food and Drug Administration